AI assistant
OneMedNet Corp — Director's Dealing 2025
Nov 27, 2025
34589_dirs_2025-11-26_d29e0ee1-b9fe-42fc-811a-a18d026865bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: OneMedNet Corp (ONMD)
CIK: 0001849380
Period of Report: 2023-11-07
Reporting Person: Green Aaron (Director, Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 600000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Senior Secured Convertible Note | $10.00 | Common Stock () | Direct | ||
| Warrants (Right to Buy) | $10.00 | 2028-11-07 | Common Stock (15956) | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs") granted to the reporting person on May 1, 2023 under the OneMedNet Corporation 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments over 24 months thereafter, subject to the reporting person's continued service with the issuer through the vesting date.
F2: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price. The PIPE Notes mature on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes.
F3: The warrants are immediately exercisable, and the exercise price is subject to anti-dilution adjustment.